Published on in Vol 14 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/70312, first published .
Therapeutic Drug Monitoring for Precision Dosing of Janus Kinase Inhibitors: Protocol for a Prospective Observational Study

Therapeutic Drug Monitoring for Precision Dosing of Janus Kinase Inhibitors: Protocol for a Prospective Observational Study

Therapeutic Drug Monitoring for Precision Dosing of Janus Kinase Inhibitors: Protocol for a Prospective Observational Study

Jérémie Tachet   1 , MSc, PharmD ;   Laurent A Decosterd   2 , PharmD, Prof Dr ;   Monia Guidi   1, 3, 4 , PhD, PD ;   François R Girardin   1, 2 , MD, Prof Dr Med

1 Service of Clinical Pharmacology, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland

2 Laboratory of Clinical Pharmacology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland

3 Centre for Research and Innovation in Clinical Pharmaceutical Sciences, Department of Education and Research, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland

4 Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, University of Lausanne, Geneva, Lausanne, Switzerland

Corresponding Author:

  • François R Girardin, MD, Prof Dr Med
  • Service of Clinical Pharmacology, Department of Medicine
  • Lausanne University Hospital and University of Lausanne
  • Rue du Bugnon 17
  • Lausanne 1011
  • Switzerland
  • Phone: 41 21 314 42 76
  • Email: francois.girardin@chuv.ch